22rv1 - OmicsDI

Show results for

Unknown (417)
Genomics (328)
Transcriptomics (149)
Proteomics (38)
Other (10)
Metabolomics (6)
Methylation profiling (5)

Organisms

Homo sapiens (200)
Andropogon gerardi (35)
Bacteria (35)
Canis lupus familiaris (35)
Cnidaria (35)
Cricetulus griseus (35)
Eukaryota (35)
Fasciola (35)
Hepatitis B virus (35)
Human betaherpesvirus 5 (35)
Madurella mycetomatis (35)
Mesocricetus auratus (35)
Miscanthus x giganteus (35)
Mus musculus (35)
Mycobacterium tuberculosis (35)
Orthoflavivirus (35)
Panicum virgatum (35)
Platyhelminthes (35)
Pseudomonas aeruginosa AES-1R (35)
Rattus norvegicus (35)
Rattus rattus (35)
Saccharomyces cerevisiae (35)
Schizosaccharomyces pombe (35)
Severe acute respiratory syndrome coronavirus 2 (35)
Shigella (35)
Sorghastrum nutans (35)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (35)
Streptococcus pneumoniae (35)
Mus musculus (4)
synthetic construct (1)

Organisms

Homo sapiens (268)
Mus musculus (4)

Repository

ENA (290)
geo (155)
biostudies-arrayexpress (43)
pride (35)
EGA (4)
NODE (4)
MassIVE (2)
MetaboLights (2)
jPOST (1)

Tissue

Cell culture (13)
Epithelial cell (6)
Prostate gland (6)
Epithelial cell of prostate (5)
Prostate cancer cell line (4)
Prostate cancer cell (3)
Cell line (2)
Private (2)
Permanent cell line cell (2)
Prostate gland epithelium (2)
B cell (1)
Cell line cell (1)
Prostate adenocarcinoma cell (1)
Prostate adenocarcinoma cell line (1)
Prostate epithelium cell line (1)

Disease

Prostate adenocarcinoma (20)
Prostate cancer (4)
Prostate carcinoma (3)
Untreated prostate cancer (1)
Acute leukemia (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (35)
Shotgun proteomics (18)
Bottom-up proteomics (10)
Data-independent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (3)
Mass spectrometry (2)
Data-dependent acquisition (2)
Gel-based experiment (2)
SWATH MS (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 2500 (1)
NextSeq 500 (1)
Orbitrap Eclipse (1)
Q Exactive (1)
Capillary electrophoresis MS - negative (1)
Capillary electrophoresis MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2016 (30)
2024 (30)
2025 (22)
2023 (22)
2021 (15)
2017 (15)
2026 (14)
2022 (14)
2020 (13)
2019 (11)
2013 (10)
2015 (8)
2010 (8)
2012 (7)
2018 (6)
2011 (4)
2014 (3)
2009 (3)
2008 (2)
2007 (1)

CHEBI ID

CHEBI:17431 (2)
CHEBI:15746 (2)
CHEBI:17148 (2)
CHEBI:16610 (2)
CHEBI:18127 (2)
CHEBI:28774 (1)
CHEBI:27847 (1)
CHEBI:25166 (1)
CHEBI:39501 (1)
CHEBI:88164 (1)
CHEBI:17434 (1)
CHEBI:28074 (1)
CHEBI:16710 (1)
CHEBI:15829 (1)
CHEBI:194704 (1)
CHEBI:4075 (1)
CHEBI:2818 (1)
CHEBI:27822 (1)
CHEBI:18189 (1)
CHEBI:5854 (1)
CHEBI:17477 (1)
CHEBI:1456 (1)
CHEBI:180089 (1)
CHEBI:36622 (1)
CHEBI:1026 (1)
CHEBI:45807 (1)
CHEBI:7035 (1)
CHEBI:16563 (1)
CHEBI:6415 (1)
CHEBI:27376 (1)

Metabolite Name

Deamido-NAD+ (1)
Malonyl CoA (1)
Isobutyryl CoA (1)
P1, P4-Di(adenosine-5') tetraphosphate (1)
CIMP (1)
Ribulose 1,5-diphosphate (1)
2',3'-cCMP (1)
2-Deoxyribose 1-phosphate (1)
Mucate (1)
Saccharate (1)
3-Indolebutyrate (1)
Dodecanoate (1)
Syringate (1)
O-Hydroxyhippurate (1)
Phenaceturate (1)
Undecanoate (1)
Serine O-sulfate (1)
Phenyl phosphate (1)
2-Quinolinecarboxylate (1)
2-Amino-3-phosphonopropionate (1)
2,3-Pyridinedicarboxylate (1)
3-(4-Hydroxyphenyl)propionate (1)
3-Phenyllactate (1)
O-Coumarate (1)
P-Coumarate (1)
N-Formylaspartate (1)
2-Hydroxyoctanoate (1)
Pelargonate (1)
2-Oxooctanoate (1)
2,4-Dihydroxypyrimidine-5-carboxylate (1)

First Public Date

2024 (53)
2023 (40)
2025 (35)
2026 (25)
2019 (24)
2021 (18)
2020 (18)
2014 (17)
2022 (16)
2017 (15)
2018 (10)
2016 (8)
2015 (8)
2013 (3)

Study type

Transcription profiling by array (28)
Other (4)
RNA-seq of coding RNA (3)
Comparative genomic hybridization by array (2)
ChIP-seq (2)
MicroRNA profiling by array (2)
Transcription profiling by RT-PCR (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (58)
2024 (46)
2023 (40)
2025 (39)
2021 (37)
2020 (36)
2019 (33)
2016 (32)
2018 (20)
2015 (19)
2017 (17)
2014 (15)
2012 (15)
2013 (12)
2010 (12)
2011 (10)
2026 (9)
2009 (5)
2008 (3)
2007 (1)
2006 (1)

Lab affiliation

Department of Chemistry, Scripps Research (3)
Faculty of Helath Sciences. University of Copenhagen. Copenhagen. Denmark (3)
Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark (2)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University (1)
Chemistry, Duke University (1)
Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC) (1)
David Geffen School of Medicine, University of California, Los Angeles, CA 90095 Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, Institute for Molecular Medicine, California NanoSystems Institute (1)
Department for BioMedical Research (DBMR) University of Bern Murtenstrasse 35 3008 Bern Switzerland (1)
Department of Biochemistry and Molecular Biology Department of Urology, Mayo clinic, Rochester MN, US (1)
Department of Chemistry, Scripps Research La Jolla, USA (1)
Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (1)
Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA (1)
Department of Urology, Henan Institute of Urology and Zhengzhou Key Laboratory for Molecular Biology of Urological Tumor Research, Department Unit of Day Surgery Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. (1)
Department of Veterinary disease biology. Faculty of health sciences. University of Copenhagen. Copehnagen. Denmark (1)
IVS. University of Copenhagen (1)
Laboratory of Peroxisome Biology and Intracellular Communication, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven, 3000 Leuven, Belgium (1)
MCTP, Rogel cancer center, Ann Arbor, Michigan, 48109 (1)
McGill University - Rosalind & Morris Goodman Cancer Research Centre (1)
Medical University of Vienna Center of Physiology and Pharmacology Department of Vascular Biology and Thrombosis Research Schwarzspanierstraße 17/I A- 1090 Vienna, Austria (1)
Nankai University (1)
Professor & Joy-Gill Chair Department of Biological Sciences and Bioengineering Indian Institute of Technology Kanpur 208016 Uttar Pradesh India (1)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (1)
Proteomics Unit, IMIBIC, Cordoba, Spain (1)
Proteomics facility, Central Science Laboratory, University of Tasmania (1)
Targeting DNA repair in systemic and radiation cancer therapy II.Medical Oncology Dept, Radiotherapy and Radiooncology Dept Research team leader: DSB repair in tumors Mildred Scheel Nachwuchszentrum HaTriCS4 (1)
University of Copenhagen. Department of Drug Design and Pharmacology (1)
Università degli Studi della Campania Luigi Vanvitelli (1)
Vancouver Prostate Centre, Vancouver, Canada (1)

Previous page
1 / 96
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 96
Next page

Sort by:

Relevance

Page size

22RV1 prostate cancer cell line transfected with SPINK1 siRNA vs control siRNA

ETS gene fusions have been characterized in a majority of prostate cancers, however key molecular alterations in ETS negative cancers are unclear. Here we used an outlier meta-analysis (meta-COPA) to identify SPINK1 outlier-expression exclusively in a subset of ETS rearrangement negative cancers (~...

ORGANISM(S): Homo sapiens

2008-06-10 | E-GEOD-11132 | biostudies-arrayexpress

Homo sapiens strain:22Rv1

Homo sapiens Raw sequence reads of 22Rv1

PRJNA1013253 | ENA

The cistrome and transcriptome landscape of androgen receptor splice variants in castration-resistant prostate cancer cells

The spliced variant forms of androgen receptor (AR-Vs) have been identified recently in castration-resistant prostate cancer (CRPC) cell lines and clinical samples. Here we identified the cistrome and transcriptome landscape of AR-Vs in CRPC cell lines and determine the clinical significance of AR v...

ORGANISM(S): Homo sapiens

2014-09-10 | E-GEOD-58478 | biostudies-arrayexpress

Homo sapiens strain:22Rv1

Rfx6 amplicon sequencing from genome edited 22Rv1 isogenic cell lines

PRJNA289208 | ENA

Human prostate carcinoma cell line 22Rv1 overexpressing ESE1

Activation of the inflammatory circuits occurs frequently in cancer cells. However the molecular details linking inflammation to transformation and progression are still unknown. In this study we report for the first time, that activation of the ETS factor ESE1 is a key event connecting inflammatory...

ORGANISM(S): Homo sapiens

2013-06-20 | E-GEOD-39668 | biostudies-arrayexpress

Development of miRNA expression signatures for induction of histone deacetylase inhibitor (part 2)

To clarify the relationship between histone acetylation and miRNA expression, we performed miRNA arrays to detect histone deacetylase inhibitor (OBP-801) induced miRNA regulating AR expression in 22Rv1. Agilent-031181 Unrestricted Human miRNA Microarray (Agilent Technologies, Santa Clara, California...

ORGANISM(S): Homo sapiens

2016-06-01 | E-GEOD-69488 | biostudies-arrayexpress

Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

PRJNA491894 | ENA

Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment

PRJNA523525 | ENA

BRD4 ChIP-Seq in 22Rv1 cells exogenously expressing HNF4G or GFP

PRJNA1072116 | ENA

RNA sequencing in 22RV1 cells stably expressing shLuc, shIMPA1, shIMPDH2

PRJNA1127502 | ENA